Coronary artery disease and stroke in HIV-infected patients: prevention and pharmacological therapy.
Boccara
Franck
F
Saint-Antoine University and Medical School, Hôpitaux de Paris, Paris, France. franck.boccara@sat.op-hop-paris.fr
Cohen
Ariel
A
D000925:Anticoagulants / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001241:Aspirin / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000453:epidemiology; D015897:Comorbidity; D003324:Coronary Artery Disease / Q000453:epidemiology* / Q000503:physiopathology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents; D015994:Incidence; D011379:Prognosis; D018570:Risk Assessment; D020521:Stroke / Q000453:epidemiology*
D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D003577:Cytochrome P-450 Enzyme System; D001241:Aspirin